Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
When Timing Matters Most: Early Relapse Outweighs Baseline Risk in Myeloma
When Timing Matters Most: Early Relapse Outweighs Baseline Risk in Myeloma
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Xinhe Shan
,
Sandra P. Susanibar‐Adaniya
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Cancer Medicine
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma
by: Sijia Yan, et al.
Published: (2025)
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL ‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
by: Niels W. C. J. van de Donk, et al.
Published: (2025)
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial
by: Ya‐Lan Zhou, et al.
Published: (2025)
Prognostic Implications of Thrombocytopenia in Chinese Patients With Newly Diagnosed Multiple Myeloma
by: Xiaojing Li, et al.
Published: (2025)
Navigating the Prognostic Complexity of IgH Cytogenetic Abnormalities in Multiple Myeloma Among Diverse IgH Cytogenetic Abnormalities–Involved High‐Risk Stratifications
by: Yanqiu Xiong, et al.
Published: (2025)